FMC Secures the Operational Business of the Dradura Group
RKGB advised Dradura on its sale to FMC, a Bremen-based investment company, after going into self-administration last August.
Category: Deals
SSW Group has launched its flagship private cryptocurrency fund
SSW Group which carries out proprietary trading in the asset classes of equities, ETPs and bonds, has launched a flagship private cryptocurrency fund as…
Liquidation of an Italian real estate AIF managed by Invesco
Invesco also assisted with the accounting and tax aspects of the transaction by Studio Vanzetta & Associati, with Partner Carlotta Veneziani and the Senior…
Advent Takes A Stake In The Parcel Logistics Company Hermes
This follows an announcement from Otto Group, that it has formed a partnership with Advent for its Hermes Group businesses in the UK and…
Clio Donates $1 Million to Help Law Firms Endure COVID-19
The legal software provider has offered financial aid to law firms impacted by the coronavirus pandemic, with a focus on enabling them to work…
Deutsche Beteiligungs’ Acquisition of Majority Stake in Cartonplast Group
Deutsche Beteiligungs AG (DBAG), a German-based listed private equity company, and DBAG-advised DBAG Fund VII entered into a share purchase agreement on 22 August…
Deal of the Year: Norwegian Infront acquires VWD group from Carlyle
Earlier this year, Global investment firm The Carlyle Group (NASDAQ: CG) had announced that it agreed to sell vwd Vereinigte Wirtschaftsdienste GmbH (vwd), a…
Media-Saturn completes the reorganization of the Greek business
The Firm’s involvement included mainly the following: Conduct of legal due diligence of the entity operating the MediaMarkt stores in Greece. They provided legal…
YFM Equity invests GBP3.6m in Wooshii
Funds advised by YFM Equity Partners (“YFM”), the specialist private equity fund manager, have backed a £3.6m investment into Wooshii Limited (“Wooshii”), a disruptive…
Calliditas Therapeutics and Everest Medicines Enter into Licensing Agreement Related to Greater China
Calliditas Therapeutics AB (“Calliditas”) and Everest Medicines II Limited (“Everest”) announced that they have entered into a license agreement, in which Everest will develop…